Steering Committee and Working Group Participants 

 

Steering Committee 

  • Victor Dzau, MD, Chair (National Academy of Medicine)
  • ADM Brett Giroir, MD, Co-Chair (US Department of Health and Human Services)
  • Ruth Katz, JD, MPH, Co-Chair (Aspen Institute)
  • Jonathan Perlin, MD, PhD, Co-Chair (HCA Healthcare)
  • Jay Bhatt, DO (American Hospital Association)
  • Carlos Blanco, MD, PhD (National Institute on Drug Abuse)
  • Helen Burstin, MD, MPH (Council of Medical Specialty Societies)
  • Kathy Chappell, PhD, RN, FNAP, FAAN (American Nurses Credentialing Center)
  • Hank Chaudhry, DO, MS, FACP, FACOI (Federation of State Medical Boards) 
  • Kelly J. Clark, MD, MBA (American Society of Addiction Medicine)
  • Deb Houry, MD, MPH (US Centers for Disease Control and Prevention)
  • Thomas J. Nasca, MD, MACP (Accreditation Council for Graduate Medical Education)
  • Andrey Ostrovsky, MD (Social Innovation Ventures)
  • Alonzo L. Plough, PhD, MPH (Robert Wood Johnson Foundation)
  • Steve Singer, PhD (Accreditation Council for Continuing Medical Education)

 

Health Professional Education and Training Working Group

  • Kathy Chappell, PhD, RN, FNAP, FAAN, Working Group Co-Lead (American Nurses Credentialing Center)
  • Thomas J. Nasca, MD, MACP, Working Group Co-Lead (Accreditation Council for Graduate Medical Education)
  • Steve Singer, PhD, Working Group Co-Lead (Accreditation Council for Continuing Medical Education)
  • Timothy K. Brennan, MD, MPH (The Addiction Medicine Foundation)
  • Robert Cain, DO (American Association of Colleges of Osteopathic Medicine)
  • Jianguo Cheng, MD, PhD (American Academy of Pain Medicine)
  • Davoren Chick, MD, FACP (American College of Physicians)
  • Charlene Dewey, MD, MEd, FACP (Vanderbilt University Medical Center)
  • Rick Garcia, PhD (American Association of Colleges of Nursing)
  • James Gifford, MD, FACP (Federation of State Medical Boards)
  • Eric Holmboe, MD, MACP, FRCP (Accreditation Council for Graduate Medical Education)
  • Beverley H. Johnson, BSN, FAAN (Institute for Patient- and Family-Centered Care)
  • Alexis LaPietra, DO (American College of Emergency Physicians)
  • Kevin Larsen, MD, FACP (Centers for Medicare and Medicaid Services)
  • Roneet Lev, MD, Office of National Drug Control Policy
  • Lucinda Maine, PhD, RPh (American Association of Colleges of Pharmacy)
  • Ray Mitchell, MD, MBA (Georgetown University and Liaison Committee on Medical Education)
  • Anne Norman, DNP, FNP-C, FAANP (American Association of Nurse Practitioners)
  • Daniel Pace, BS, CCME (American Academy of Physician Assistants) 
  • Margot Savoy, MD, MPH, FAAFP (American Academy of Family Physicians) 
  • Denice Stewart, DDA, MHSA, (American Dental Education Association)
  • Sherin Tooks, EdD, MS (Commission on Dental Accreditation)
  • Alison Whelan, MD (Association of American Medical Colleges)

 

Pain Management Guidelines and Evidence Standards Working Group

  • Helen Burstin, MD, MPH, Working Group Co-Lead (Council of Medical Specialty Societies)
  • Debra Houry, MD, MPH, Working Group Co-Lead (US Centers for Disease Control and Prevention)
  • Rebecca Baker, PhD (National Institutes of Health)
  • Alison Bramhall, MPH (American Dental Association)
  • Anne L. Burns, BSPharm, RPh (American Pharmacists Association)
  • Roger Chou, MD (Oregon Health and Science University)
  • Anna Dopp, PharmD (American Society of Health-System Pharmacists)
  • Kyle P. Edmonds, MD, FAAHPM (American Academy of Hospice and Palliative Medicine)
  • Mary R. Grealy, JD (Healthcare Leadership Council)
  • Nicole Harrington, BS (CVS Health)
  • Lisa Hines, PharmD (Pharmacy Quality Alliance)
  • Roneet Lev, MD, Office of National Drug Control Policy
  • Shari Ling, MD (Centers for Medicare and Medicaid Services)
  • Jan Losby, PhD, MSW (US Centers for Disease Control and Prevention)
  • Edward Mariano, MD, MS (American Society of Anesthesiologists)
  • Vincent G. Nelson, MD, MBA (Blue Cross Blue Shield Association)
  • Robert “Chuck” Rich, Jr., MD, FAAFP (American Academy of Family Physicians)
  • Friedhelm Sandbrink, MD (US Department of Veterans Affairs)
  • Michael Schlosser, MD, MBA (HCA Healthcare)
  • Bob Twillman, PhD (Integrative Health Policy Consortium)
  • Scott G. Weiner, MD, MPH, FAAEM, FACEP (American College of Emergency Physicians)

 

Prevention, Treatment, and Recovery Services Working Group 

  • Jay Bhatt, DO, MPH, MPA, FACP, Working Group Co-Lead (American Hospital Association)
  • Andrey Ostrovsky, MD, Working Group Co-Lead (Social Innovation Ventures)
  • Alonzo Plough, PhD, MPH, Working Group Co-Lead (Robert Wood Johnson Foundation)
  • Mitra Ahadpour, MD, DABAM (US Food and Drug Administration)
  • Jennifer Atkins, MBA (Blue Cross Blue Shield Association)
  • George Barrett, MBA (Columbia University Mailman School of Public Health )
  • David Beier, JD (Bay City Capital)
  • Kirsten Beronio, JD (Centers for Medicare and Medicaid Services)
  • Carlos Blanco, MD, PhD (National Institute on Drug Abuse)
  • Richard Bonnie, LLB (University of Virginia) 
  • Kelly J. Clark, MD, MBA (American Society of Addiction Medicine)
  • Allan Coukell, BSc (The Pew Charitable Trust)
  • Anna Dopp, PharmD (American Society of Health-System Pharmacists)
  • Ed Greissing, MA (Milken Institute)
  • Mira Irons, MD (American Medical Association) 
  • Christopher M. Jones, PharmD, MPH (US Centers for Disease Control and Prevention)
  • Daniel Knecht, AETNA
  • Roneet Lev, MD, Office of National Drug Control Policy
  • Bertha K. Madras, PhD (McLean Hospital and Harvard Medical School)
  • Mark O’Brien, JD (Addiction Policy Forum)
  • Harold L. Paz, MD (The Ohio State University)
  • Marcus Plescia, MD, MPH (Association of State and Territorial Health Officials)
  • Carter Roeber, (SAMHSA)
  • Elizabeth Salisbury-Afshar, MD, MPH (American Institutes for Research)
  • Umair Shah, MD, MPH (Harris County Public Health)
  • Joshua Sharfstein, MD (John Hopkins University Bloomberg School of Public Health)
  • Brooke Tranium, JD (American Nurses Association)
  • Corey Waller, MD, MS (Health Management Associates) 

 

Research, Data, and Metrics Needs Working Group

  • Carlos Blanco, MD, PhD, Working Group Co-Lead (National Institute on Drug Abuse)
  • Kelly J. Clark, MD, MBA, Working Group Co-Lead (American Society of Addiction Medicine)
  • Rebecca Baker, PhD (National Institutes of Health)
  • David Beier, JD (Bay City Capital)
  • Richard Bonnie, LLB (University of Virginia)
  • Kathy Chappell, PhD, RN, FNAP, FAAN (American Nurses Credentialing Center)
  • Jianguo Cheng, MD, PhD (American Academy of Pain Medicine)
  • James Gifford, MD, FACP (Federation of State Medical Boards)
  • Nicole Harrington, BS (CVS Health)
  • Lisa Hines, PharmD (Pharmacy Quality Alliance)
  • Christopher M. Jones, PharmD, MPH (US Centers for Disease Control and Prevention)
  • Bertha K. Madras, PhD (McLean Hospital and Harvard Medical School)
  • Edward Mariano, MD, MS (American Society of Anesthesiologists)
  • Friedhelm Sandbrink, MD (US Department of Veterans Affairs)

 

The Action Collaborative serves as a neutral platform through which to facilitate dialog and discussion among representatives from multiple sectors around topics of mutual interest and concern. Individual participating members of the Opioid Action Collaborative have disclosed any perceived or actual interests (financial, organizational, professional, or personal in nature) relevant to the activities of the Action Collaborative. Summaries of relevant interests reported can be found here.

 

For more information regarding working groups, please contact opioidcollaborative@nas.edu.

 

Back to Action Collaborative Homepage


Join Our Community

Sign up for NAM email updates